Wed, Sep 3, 2014, 1:20 AM EDT - U.S. Markets open in 8 hrs 10 mins

Recent

% | $
Quotes you view appear here for quick access.

Oncolytics Biotech Inc. Message Board

  • carrivechio carrivechio Jan 4, 2013 12:56 PM Flag

    Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases

    Search: ONCY headlines:

    Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases

    NEW YORK, NY--(Marketwire - Jan 2, 2013) - The Biotech Industry has skyrocketed in 2012 as an increase in the number of new drug approvals has boosted investor optimism within the industry.

    "In 2011, the U.S. FDA approved 30 new drugs, compared to 21 in 2010," S&P Capital IQ wrote in a note. "Through September 2012, the year-to-date total was 22. We see an improving trend for FDA first cycle review approvals and a rise in the rate of new drug approvals for rare diseases, which we think is helping to boost investor sentiment for the agency, after years of criticism stemming from inconsistency in making and communicating its decisions."

    Another key factor in the Biotech Industry's success has been the "patent cliff" major pharmaceuticals have faced in 2012. Major drug manufacturers have looked to biotech companies to help offset major revenue losses from expiring patents as it is less time consuming than developing new drugs through R&D.

 
ONCY
1.30-0.08(-5.80%)Sep 2 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.